ResultsIQ

ResultsIQ › Latest results › Gaudium IVF and Women Health Limited

Gaudium IVF and Women Health Limited Q1 FY27 results press release summary

NSE: GAUDIUMIVF · BSE: 544709

Results press release of 13 Aug 2026, summarised by AI from the filing.

Gaudium IVF Q1 FY27 revenue ₹19.4 cr, up 9.13% YoY; EBITDA ₹2.4 cr, margin 12.51%, on expansion costs.

Key takeaways

  1. FY27 expansion 10 hubs planned in FY27, one operational at South Extension; 8 new centres in FY28 and 1 in FY29.
  2. EBITDA decline EBITDA fell to ₹2.4 cr from ₹5.2 cr, margin 12.51%, on expansion-related one-off costs.
  3. Growth driver Higher patient volumes at mature hubs, advanced IVF protocols, and international patients drove revenue.

Original filing on BSE

Gaudium IVF and Women Health Limited Q1 FY27 results

As filed: Revenue ₹19.4 cr, EBITDA ₹2.4 cr, PAT ₹1.8 cr, EBITDA margin 12.5%.

Not scored. Too small to score: quarter revenue ₹19.4 cr is below the ₹20.0 cr minimum. On a base this small, percentage changes say little.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹30.4 cr, EBITDA ₹12.2 cr, PAT ₹8.4 cr, EBITDA margin 40.1%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹30.4 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: −7.0% in 28 days (Nifty 500: +0.6%).
  • Q3 FY26: Revenue ₹24.5 cr, EBITDA ₹6.6 cr, PAT ₹3.6 cr, EBITDA margin 26.7%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹24.5 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +2.2% in 30 days (Nifty 500: +4.3%).

Past price moves after results do not indicate future moves. Not a recommendation.

Gaudium IVF and Women Health Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.